Sphera Funds Management as of Dec. 31, 2020
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 105 positions in its portfolio as reported in the December 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Sarepta Therapeutics (SRPT) | 7.9 | $89M | 520k | 170.49 | |
Merck & Co (MRK) | 6.2 | $70M | 859k | 81.80 | |
Eli Lilly & Co. (LLY) | 6.1 | $69M | 410k | 168.84 | |
Abbvie (ABBV) | 5.4 | $61M | 565k | 107.15 | |
Johnson & Johnson (JNJ) | 4.7 | $53M | 338k | 157.38 | |
Novartis Sponsored Adr (NVS) | 4.6 | $52M | 549k | 94.43 | |
Spdr Ser Tr Put Put Option (XBI) | 3.7 | $42M | 300k | 140.78 | |
Bristol Myers Squibb (BMY) | 3.4 | $39M | 625k | 62.03 | |
Astrazeneca Sponsored Adr (AZN) | 3.1 | $35M | 691k | 49.99 | |
Oncorus | 2.5 | $28M | 903k | 31.44 | |
Sigilon Therapeutics | 2.3 | $26M | 568k | 45.93 | |
Generac Holdings (GNRC) | 2.1 | $24M | 106k | 227.41 | |
Nice Sponsored Adr (NICE) | 1.9 | $21M | 75k | 283.54 | |
Syndax Pharmaceuticals (SNDX) | 1.5 | $17M | 746k | 22.24 | |
Kura Oncology (KURA) | 1.4 | $15M | 472k | 32.66 | |
C4 Therapeutics Com Stk (CCCC) | 1.3 | $15M | 444k | 32.90 | |
Palo Alto Networks (PANW) | 1.2 | $14M | 38k | 355.39 | |
Cerevel Therapeutics Hldng I (CERE) | 1.2 | $14M | 812k | 16.58 | |
Audiocodes Ord (AUDC) | 1.0 | $12M | 429k | 27.55 | |
Zymeworks | 1.0 | $12M | 245k | 47.26 | |
Alx Oncology Hldgs (ALXO) | 1.0 | $12M | 133k | 86.20 | |
Kornit Digital SHS (KRNT) | 1.0 | $11M | 128k | 89.13 | |
Bridgebio Pharma (BBIO) | 1.0 | $11M | 158k | 71.11 | |
Facebook Cl A (META) | 1.0 | $11M | 40k | 273.16 | |
Microsoft Corporation (MSFT) | 0.9 | $11M | 48k | 222.42 | |
Celldex Therapeutics Com New (CLDX) | 0.9 | $11M | 597k | 17.52 | |
Zentalis Pharmaceuticals (ZNTL) | 0.9 | $9.9M | 191k | 51.94 | |
Alexion Pharmaceuticals | 0.8 | $9.4M | 60k | 156.23 | |
Trillium Therapeutics Com New | 0.8 | $9.2M | 627k | 14.71 | |
Kymera Therapeutics (KYMR) | 0.8 | $9.2M | 148k | 62.00 | |
Burlington Stores (BURL) | 0.8 | $9.2M | 35k | 261.54 | |
Avrobio Ord (AVRO) | 0.8 | $9.1M | 656k | 13.94 | |
Varonis Sys (VRNS) | 0.8 | $9.0M | 55k | 163.60 | |
Immatics SHS (IMTX) | 0.8 | $8.9M | 823k | 10.79 | |
Camtek Ord (CAMT) | 0.8 | $8.8M | 400k | 21.91 | |
I Mab Sponsored Ads (IMAB) | 0.8 | $8.6M | 182k | 47.15 | |
Verint Systems (VRNT) | 0.8 | $8.5M | 127k | 67.18 | |
Cogent Biosciences (COGT) | 0.7 | $8.3M | 735k | 11.23 | |
Silverback Therapeutics (SPRY) | 0.7 | $8.1M | 174k | 46.34 | |
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.7 | $8.0M | 833k | 9.65 | |
Immunovant (IMVT) | 0.7 | $7.9M | 170k | 46.19 | |
Uniqure Nv SHS (QURE) | 0.7 | $7.8M | 216k | 36.13 | |
Repare Therapeutics Ord (RPTX) | 0.7 | $7.7M | 224k | 34.30 | |
Fate Therapeutics (FATE) | 0.7 | $7.5M | 82k | 90.93 | |
Beyondspring SHS (BYSI) | 0.6 | $7.3M | 598k | 12.20 | |
Verona Pharma Sponsored Ads (VRNA) | 0.6 | $7.2M | 1.0M | 7.00 | |
Bcls Acquisition Corp Com Cl A | 0.6 | $6.9M | 625k | 11.03 | |
Amazon (AMZN) | 0.6 | $6.7M | 2.1k | 3257.16 | |
Mirati Therapeutics | 0.6 | $6.5M | 30k | 219.65 | |
Y Mabs Therapeutics (YMAB) | 0.6 | $6.5M | 131k | 49.51 | |
Oric Pharmaceuticals (ORIC) | 0.5 | $6.2M | 182k | 33.85 | |
Amicus Therapeutics (FOLD) | 0.5 | $6.1M | 266k | 23.09 | |
Krystal Biotech (KRYS) | 0.5 | $6.1M | 101k | 60.00 | |
Deciphera Pharmaceuticals (DCPH) | 0.5 | $5.9M | 104k | 57.07 | |
Iovance Biotherapeutics (IOVA) | 0.5 | $5.9M | 127k | 46.40 | |
Allot SHS (ALLT) | 0.5 | $5.6M | 533k | 10.52 | |
NOVA MEASURING Instruments L (NVMI) | 0.5 | $5.5M | 78k | 70.60 | |
Praxis Precision Medicines I | 0.5 | $5.5M | 100k | 55.02 | |
Arko Corp (ARKO) | 0.5 | $5.4M | 600k | 9.00 | |
Vistagen Therapeutics Com New | 0.5 | $5.3M | 2.7M | 1.94 | |
Ionis Pharmaceuticals (IONS) | 0.5 | $5.2M | 92k | 56.54 | |
Concert Pharmaceuticals I equity | 0.4 | $4.9M | 384k | 12.64 | |
Galera Therapeutics (GRTX) | 0.4 | $4.8M | 468k | 10.23 | |
Dicerna Pharmaceuticals | 0.4 | $4.8M | 217k | 22.03 | |
Galecto (GLTO) | 0.4 | $4.7M | 392k | 11.92 | |
Essa Pharma Com New (EPIX) | 0.4 | $4.7M | 390k | 11.93 | |
Kalvista Pharmaceuticals (KALV) | 0.4 | $4.6M | 240k | 18.99 | |
Jfrog Ord Shs (FROG) | 0.4 | $4.5M | 72k | 62.82 | |
Sutro Biopharma (STRO) | 0.4 | $4.4M | 202k | 21.71 | |
Arya Sciences Acquisition Com Cl A | 0.4 | $4.3M | 400k | 10.85 | |
Rocket Pharmaceuticals (RCKT) | 0.4 | $4.1M | 75k | 54.84 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 0.3 | $3.9M | 24k | 166.79 | |
Wave Life Sciences SHS (WVE) | 0.3 | $3.3M | 415k | 7.87 | |
Chinook Therapeutics | 0.3 | $3.2M | 202k | 15.86 | |
Shattuck Labs (STTK) | 0.3 | $2.9M | 55k | 52.41 | |
Argenx Se Sponsored Adr (ARGX) | 0.2 | $2.7M | 9.2k | 294.09 | |
Alpine Immune Sciences (ALPN) | 0.2 | $2.5M | 198k | 12.60 | |
Springworks Therapeutics (SWTX) | 0.2 | $2.3M | 31k | 72.52 | |
Yumanity Therapeutics | 0.2 | $2.2M | 130k | 17.00 | |
Dyne Therapeutics (DYN) | 0.2 | $2.1M | 100k | 21.00 | |
Aligos Therapeutics (ALGS) | 0.2 | $2.0M | 74k | 27.65 | |
Athira Pharma (ATHA) | 0.2 | $1.8M | 54k | 34.25 | |
Leap Therapeutics | 0.2 | $1.8M | 800k | 2.25 | |
Ion Acquisition Corp 1 Shs Cl A | 0.2 | $1.8M | 150k | 11.77 | |
89bio (ETNB) | 0.2 | $1.7M | 70k | 24.36 | |
Bioatla (BCAB) | 0.2 | $1.7M | 50k | 34.02 | |
Inhibrx (INBX) | 0.1 | $1.4M | 43k | 32.98 | |
Pieris Pharmaceuticals (PIRS) | 0.1 | $1.4M | 550k | 2.50 | |
Bioxcel Therapeutics (BTAI) | 0.1 | $1.3M | 28k | 46.20 | |
Health Sciences Acq Corp 2 Ord Shs | 0.1 | $1.3M | 100k | 12.81 | |
Lifesci Acquisition Ii Corp | 0.1 | $1.1M | 100k | 10.62 | |
Kronos Bio (KRON) | 0.1 | $1.0M | 35k | 29.86 | |
Vincera Pharma (VINC) | 0.1 | $972k | 47k | 20.92 | |
Aclaris Therapeutics (ACRS) | 0.1 | $971k | 150k | 6.47 | |
Cerevel Therapeutics Hldng I *w Exp 06/09/202 (CEREW) | 0.1 | $940k | 166k | 5.65 | |
Nice Sys Note 1.250% 1/1 | 0.1 | $856k | 250k | 3.42 | |
Sage Therapeutics (SAGE) | 0.1 | $740k | 8.6k | 86.51 | |
Olema Pharmaceuticals (OLMA) | 0.1 | $731k | 15k | 48.09 | |
Miragen Therapeutics | 0.0 | $502k | 31k | 16.46 | |
Gamida Cell SHS (GMDA) | 0.0 | $336k | 40k | 8.40 | |
Immatics *w Exp 07/01/202 (IMTXW) | 0.0 | $288k | 100k | 2.88 | |
Therapeutics Acquisition Cor Com Cl A | 0.0 | $279k | 20k | 13.95 | |
Cellectar Biosciences Com Par | 0.0 | $182k | 88k | 2.08 | |
Orgenesis Com New (ORGS) | 0.0 | $161k | 36k | 4.51 | |
Outlook Therapeutics *w Exp 02/18/202 | 0.0 | $29k | 130k | 0.22 |